These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36189296)

  • 1. m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent.
    Kong J; Lu S; Zhang L; Yao Y; Zhang J; Shen Z; Luo M; Liu B; Zheng J; Lin T
    Front Immunol; 2022; 13():1014861. PubMed ID: 36189296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new m6A methylation-related gene signature for prognostic value in patient with urothelial carcinoma of the bladder.
    Zheng B; Wang J; Zhao G; Chen X; Yao Z; Niu Z; He W
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33779704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial Infarction.
    Wang X; Wu Y; Guo R; Zhao L; Yan J; Gao C
    J Immunol Res; 2022; 2022():5173761. PubMed ID: 36061306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma.
    Chen S; Zhang N; Wang T; Zhang E; Wang X; Zheng J
    Front Immunol; 2020; 11():1900. PubMed ID: 32983112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-methyladenosine regulators are potential prognostic biomarkers for multiple myeloma.
    Wang J; Zuo Y; Lv C; Zhou M; Wan Y
    IUBMB Life; 2023 Feb; 75(2):137-148. PubMed ID: 36177774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor mutational burden related classifier is predictive of response to PD-L1 blockade in locally advanced and metastatic urothelial carcinoma.
    Wang Y; Chen L; Ju L; Xiao Y; Wang X
    Int Immunopharmacol; 2020 Oct; 87():106818. PubMed ID: 32738594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
    Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
    Front Immunol; 2022; 13():976107. PubMed ID: 36091006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of m6A regulators and the nomogram construction in glioma patients.
    Liu P; Yan X; Ma C; Gu J; Tian F; Qu J
    Medicine (Baltimore); 2022 Sep; 101(37):e30643. PubMed ID: 36123877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of clinical prognostic features of esophageal cancer based on m6A regulators.
    Wang H; Zhang Y; Chen L; Liu Y; Xu C; Jiang D; Song Q; Wang H; Wang L; Lin Y; Chen Y; Chen J; Xu Y; Hou Y
    Front Immunol; 2022; 13():950365. PubMed ID: 36159855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atezolizumab in locally advanced or metastatic urothelial cancer: a pooled analysis from the Spanish patients of the IMvigor 210 cohort 2 and 211 studies.
    Sotelo M; Alonso-Gordoa T; Gajate P; Gallardo E; Morales-Barrera R; Pérez-Gracia JL; Puente J; Sánchez P; Castellano D; Durán I
    Clin Transl Oncol; 2021 Apr; 23(4):882-891. PubMed ID: 32897497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pre-operative Nomogram for Prediction of Lymph Node Metastasis in Bladder Urothelial Carcinoma.
    Lu X; Wang Y; Jiang L; Gao J; Zhu Y; Hu W; Wang J; Ruan X; Xu Z; Meng X; Zhang B; Yan F
    Front Oncol; 2019; 9():488. PubMed ID: 31293963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the prognostic significance and potential mechanisms of lncRNAs associated with m6A methylation in papillary thyroid carcinoma.
    Huang Y; Li X; Chen W; He Y; Wu S; Li X; Hou B; Wang S; He Y; Jiang H; Lun Y; Zhang J
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108286. PubMed ID: 34735975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
    Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the prognostic potential of m6A methylation regulators in low-grade glioma: implications for tumor microenvironment modulation.
    Wu H; Chen S; Hu Z; Ge R; Ma L; You C; Huang Y
    Eur J Med Res; 2024 Jan; 29(1):19. PubMed ID: 38173044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m6A regulator-mediated RNA methylation modification patterns are involved in the regulation of the immune microenvironment in ischaemic cardiomyopathy.
    Zheng PF; Hong XQ; Liu ZY; Zheng ZF; Liu P; Chen LZ
    Sci Rep; 2023 Apr; 13(1):5904. PubMed ID: 37041267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a m
    Chen J; Yu K; Zhong G; Shen W
    Cancer Cell Int; 2020; 20():157. PubMed ID: 32419773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants of response to PD-L1 blockade across tumor types.
    Banchereau R; Leng N; Zill O; Sokol E; Liu G; Pavlick D; Maund S; Liu LF; Kadel E; Baldwin N; Jhunjhunwala S; Nickles D; Assaf ZJ; Bower D; Patil N; McCleland M; Shames D; Molinero L; Huseni M; Sanjabi S; Cummings C; Mellman I; Mariathasan S; Hegde P; Powles T
    Nat Commun; 2021 Jun; 12(1):3969. PubMed ID: 34172722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
    Shen C; Liu J; Yang X; Jiao W; Wang Y
    Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis.
    Wu T; Qian TY; Lin RJ; Jin DD; Xu XB; Huang MX; Ji J; Jiang F; Pan LL; Luo L; Ji YF; Chen QL; Xiao MB
    J Gastrointest Oncol; 2022 Oct; 13(5):2553-2564. PubMed ID: 36388690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.